Role of tumour markers in monitoring epithelial ovarian cancer

被引：1
|
作者：
Meyer, T [1 ]
Rustin, GJS [1 ]
机构：
[1] Mt Vernon Hosp, Dept Med Oncol, Northwood HA6 2RN, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 2000年 / 82卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Currently the only tumour marker to have a well-defined and validated role in the management of ovarian cancer is CA125. Changes in the level of CA125 can be used as a reliable indication of response or progression according to various criteria, but it does not yet have a clear place in diagnosis or prognosis. Its value as part of a screening tool and during routine follow-up remain the subject of ongoing trials. Other markers remain experimental and do not have a well-defined contribution to make at present. (C) 2000 Cancer Research Campaign.
引用
收藏
页码：1535 / 1538
页数：4
相关论文
共 50 条
  • [1] Role of tumour markers in monitoring epithelial ovarian cancer
    T Meyer
    G J S Rustin
    British Journal of Cancer, 2000, 82 (9) : 1535 - 1538
  • [2] Use of tumour markers in monitoring the course of ovarian cancer
    Rustin, GJS
    Nelstrop, AE
    Bentzen, SM
    Piccart, MJ
    Bertelsen, K
    ANNALS OF ONCOLOGY, 1999, 10 : 21 - 27
  • [3] Tumour markers in ovarian cancer
    Kehoe, S
    Selman, T
    HOSPITAL MEDICINE, 2001, 62 (08): : 452 - 453
  • [4] Molecular markers in epithelial ovarian cancer: Their role in prognosis and therapy
    Zagouri, F.
    Dimopoulos, M. A.
    Bournakis, E.
    Papadimitriou, C. A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (03) : 268 - 277
  • [5] Clinical tumour markers in ovarian cancer
    Mazurek, A
    Niklinski, J
    Laudanski, T
    Pluygers, E
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 (01) : 23 - 35
  • [6] Targeting tumour markers in ovarian cancer treatment
    Preetam, Subham
    Mondal, Sagar
    Priya, Swati
    Bora, Jutishna
    Ramniwas, Seema
    Rustagi, Sarvesh
    Qusty, Naeem F.
    Alghamdi, Saad
    Babalghith, Ahmad O.
    Siddiqi, Abdullah
    Malik, Sumira
    CLINICA CHIMICA ACTA, 2024, 559
  • [7] GLYCODELINS AS TUMOUR-MARKERS IN OVARIAN CANCER
    Scholz, C.
    Mayr, D.
    Lenhardt, M.
    Tsvilina, A.
    Schumacher, L.
    Friese, K.
    Jeschke, U.
    TUMOR BIOLOGY, 2010, 31 : S108 - S108
  • [8] Searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers
    Tang, Yinlin
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (01) : 458 - 458
  • [9] Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers
    Borella, Fulvio
    Bertero, Luca
    Valabrega, Giorgio
    Fucina, Stefano
    Cassoni, Paola
    Benedetto, Chiara
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 164 (01) : 262 - 269
  • [10] Role of laparoscopy in initial tumour staging in advanced epithelial ovarian cancer: a systematic review
    Zeff, Natalia
    PLEURA AND PERITONEUM, 2018, 3 (01)
12345